TY - JOUR
T1 - Molecular analysis of TSC1 and TSC2 genes and phenotypic correlations in Brazilian families with tuberous sclerosis
AU - Rosset, Clévia
AU - Vairo, Filippo
AU - Bandeira, Isabel Cristina
AU - Correia, Rudinei Luis
AU - De Goes, Fernanda Veiga
AU - Da Silva, Raquel Tavares Boy
AU - Bueno, Larissa Souza Mario
AU - De Miranda Gomes, Mireille Caroline Silva
AU - De Campos Reis Galvão, Henrique
AU - Neri, João I.C.F.
AU - Achatz, Maria Isabel
AU - Netto, Cristina Brinckmann Oliveira
AU - Ashton-Prolla, Patricia
N1 - Funding Information:
Funding:WewouldliketothankFundode IncentivoàPesquisaeEventos(FIPE)ofHospital de Clı ´ nicas de Porto Alegre, Conselho Nacional de Desenvolvimento Cientı ´ fico e Tecnolo ´ gico (CNPq) andInstitutodoCa ˆ ncerInfantil(ICI)forfinancial support.
Publisher Copyright:
© 2017 Rosset et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2017/10
Y1 - 2017/10
N2 - Tuberous sclerosis complex (TSC) is an autosomal dominant multisystem disorder characterized by the development of multiple hamartomas in many organs and tissues. It occurs due to inactivating mutations in either of the two genes, TSC1 and TSC2, following a second hit in a tumor suppressor gene in most hamartomas. Comprehensive screening for mutations in both the TSC1 and TSC2 loci has been performed in several cohorts of patients and a broad spectrum of pathogenic mutations have been described. In Brazil, there is no data regarding incidence and prevalence of tuberous sclerosis and mutations in TSC1 and TSC2. We analyzed both genes in 53 patients with high suspicion of tuberous sclerosis using multiplex-ligation dependent probe amplification and a customized next generation sequencing panel. Confirmation of all variants was done by the Sanger method. We identified 50 distinct variants in 47 (89%) of the patients. Five were large rearrangements and 45 were point mutations. The symptoms presented by our series of patients were not different between male and female individuals, except for the more common occurrence of shagreen patch in women (p = 0.028). In our series, consistent with other studies, TSC2 mutations were associated with a more severe phenotypic spectrum than TSC1 mutations. This is the first study that sought to characterize the molecular spectrum of Brazilian individuals with tuberous sclerosis.
AB - Tuberous sclerosis complex (TSC) is an autosomal dominant multisystem disorder characterized by the development of multiple hamartomas in many organs and tissues. It occurs due to inactivating mutations in either of the two genes, TSC1 and TSC2, following a second hit in a tumor suppressor gene in most hamartomas. Comprehensive screening for mutations in both the TSC1 and TSC2 loci has been performed in several cohorts of patients and a broad spectrum of pathogenic mutations have been described. In Brazil, there is no data regarding incidence and prevalence of tuberous sclerosis and mutations in TSC1 and TSC2. We analyzed both genes in 53 patients with high suspicion of tuberous sclerosis using multiplex-ligation dependent probe amplification and a customized next generation sequencing panel. Confirmation of all variants was done by the Sanger method. We identified 50 distinct variants in 47 (89%) of the patients. Five were large rearrangements and 45 were point mutations. The symptoms presented by our series of patients were not different between male and female individuals, except for the more common occurrence of shagreen patch in women (p = 0.028). In our series, consistent with other studies, TSC2 mutations were associated with a more severe phenotypic spectrum than TSC1 mutations. This is the first study that sought to characterize the molecular spectrum of Brazilian individuals with tuberous sclerosis.
UR - http://www.scopus.com/inward/record.url?scp=85030241668&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030241668&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0185713
DO - 10.1371/journal.pone.0185713
M3 - Article
C2 - 28968464
AN - SCOPUS:85030241668
SN - 1932-6203
VL - 12
JO - PLoS One
JF - PLoS One
IS - 10
M1 - e0185713
ER -